- Home
- SMTI vs NMRA Comparison
SMTI vs NMRA Comparison
Compare SMTI & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SMTI | NMRA |
|---|---|---|
| Founded | 1982 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 186.9M | 424.4M |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | SMTI | NMRA |
|---|---|---|
| Price | $22.93 | $1.65 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 8 |
| Target Price | ★ $41.00 | $8.00 |
| AVG Volume (30 Days) | 44.5K | ★ 821.7K |
| Earning Date | 11-12-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $101,877,532.00 | N/A |
| Revenue This Year | $21.60 | N/A |
| Revenue Next Year | $16.70 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 30.52 | N/A |
| 52 Week Low | $18.90 | $0.61 |
| 52 Week High | $38.68 | $11.42 |
Technical Indicators
Market Signals| Indicator | SMTI | NMRA |
|---|---|---|
| Relative Strength Index (RSI) | 43.72 | 32.99 |
| Support Level | $23.76 | $1.73 |
| Resistance Level | $25.41 | $1.93 |
| Average True Range (ATR) | 1.07 | 0.12 |
| MACD | -0.04 | -0.00 |
| Stochastic Oscillator | 3.33 | 13.64 |
Price Performance
Historical ComparisonAbout SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.